DELRAY BEACH, Fla., Could 09, 2022 (GLOBE NEWSWIRE) — PetMed Categorical, Inc. ( PETS), Your Most Trusted Pet Well being Skilled, in the present day publicizes the appointment of former Petco government Carolyn Carden as VP of Product Administration. On this function, Carden shall be accountable for scaling the PetMeds manufacturing imaginative and prescient, together with its telemedicine enterprise and expanded product portfolio.
“Carolyn’s expertise in scaling product, IT, and merchandising for giant, high-growth organizations is a big asset to PetMeds,” mentioned Matt Hulett, CEO and President of PetMed Categorical. “We’re quickly re-imaging our firm right into a growth-oriented pet well being professional, and I’m thrilled to have such a seasoned visionary and excellent pet product chief.”
Carden brings greater than 20 years of strategic management and sensible, hands-on expertise in eCommerce, product administration, and operations throughout various channels and industries. Most lately, she led key product groups at Petco to design and launch options, together with “purchase on-line, choose up in retailer,” on-line grooming appointment reserving, and deploying handheld gadgets to over 1,500 retail, veterinary, and cellular areas.
“PetMeds is in an enviable market place with over 2 million pet dad and mom and a community of tens of hundreds of veterinarians,” mentioned Carden, who’s the pet mother or father of Rizzo, a 5-year-old Doberman. “Because the wants for customized and professional pet healthcare improve, PetMeds can construct upon their legacy of unbelievable service, which inevitably creates happier and more healthy pets.”
Based in 1996, PetMed Categorical is Your Most Trusted Pet Well being Skilled, delivering prescription and non-prescription pet medicines and different well being merchandise for canine, cats, and horses direct to the patron at aggressive costs via its web site at petmeds.com and likewise via its 1-800-PetMeds toll free quantity.
This press launch could include “forward-looking” statements, as outlined within the Personal Securities Litigation Reform Act of 1995 or by the Securities and Alternate Fee, that contain quite a lot of dangers and uncertainties, together with the Firm’s capability to satisfy the goals included in its marketing strategy. Vital elements that would trigger outcomes to vary materially from these indicated by such “forward-looking” statements are set forth in Administration’s Dialogue and Evaluation of Monetary Situation and Outcomes of Operations within the PetMed Categorical Annual Report on Kind 10-Okay for the 12 months ended March 31, 2021. The Firm’s future outcomes may be impacted by different threat elements listed now and again in its SEC filings, together with, however not restricted to, the Firm’s Kind 10-Q and its Annual Report on Kind 10-Okay.
For funding relations contact PetMed Categorical, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444, [email protected]
For media relations contact Butin PR, Mary Eva Tredway, [email protected]